A method for treating a patient suffering from Post-Polio Syndrome (PPS)comprises the intravenous, intramuscular or subcutaneous administration of apharmacologically effective amount of an immunomodulating agent, in particulargamma-globulin. Also disclosed is the use of the immunomodulating agent forthe manufacture of a corresponding medicament, and a pharmaceuticalcomposition for treatment of PPS comprising gamma-globulin.
展开▼